Reports
Reports
The global pharmaceutical excipients market is projected to attain USD 10.6 billion by 2028, rising from USD 8.3 billion in 2022, and growing at a CAGR of 4.1% between 2023 and 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A pharmaceutical excipient, also referred to as a bulking agent, diluent, or filler, is an organic or synthetic product formulated with the active ingredient of a drug, included in a pharmaceutical dosage form to assist in the manufacturing process to protect, support, or enhance stability, or for bioavailability. They also help to identify products and improve general product safety or functionality during storage or use.
The pharmaceutical excipients market can be divided based on segments like product, functionality, and formulation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The pharmaceutical excipients market can be divided based on its product as organic chemicals and inorganic chemicals. Organic chemicals can be further subdivided into oleochemicals, carbohydrates, petrochemicals, and proteins. Carbohydrates are also further subdivided into sugars, cellulose, and starch. Inorganic chemicals, meanwhile, are divided into calcium phosphate, metal oxides, halites, calcium carbonate, and calcium sulphate. The pharmaceutical excipients market can be broadly categorised based on its formulation into:
The pharmaceutical excipients market can be divided on the basis of its functionality into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others.
The EMR report looks into the regional pharmaceutical excipients market like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The pharmaceutical excipients market is driven by factors such as the growing pharmaceutical industry combined with advances in functional excipients, increased use of orphan drugs, and the increased use of biopharmaceuticals. The advent of multifunctional excipients, the shifting focus of pharmaceutical manufacturing to emerging markets, and the increasing biosimilar sector also pose important growth possibilities in the pharmaceutical excipients market for the market players.
The report presents a detailed analysis of the following key players in the global pharmaceutical excipients market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Functionality |
|
Breakup by End User |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pharmaceutical Excipients Market Overview
3.1 Global Pharmaceutical Excipients Market Historical Value (2016-2022)
3.2 Global Pharmaceutical Excipients Market Forecast Value (2023-2031)
4 Global Pharmaceutical Excipients Market Landscape
4.1 Global Pharmaceutical Excipients Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pharmaceutical Excipients Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Functionality
4.2.3 Analysis by End Users
5 Global Pharmaceutical Excipients Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pharmaceutical Excipients Market Segmentation
6.1 Global Pharmaceutical Excipients Market by Product Type
6.1.1 Market Overview
6.1.2 Polymers
6.1.2.1 MCC
6.1.2.2 HPMC
6.1.2.3 Ethyl Cellulose
6.1.2.4 Methyl Cellulose
6.1.2.5 CMC
6.1.2.6 Croscarmellose Sodium
6.1.2.7 Povidone
6.1.2.8 Pregelatinized starch
6.1.2.9 Sodium starch glycolate
6.1.2.10 Polyethylene Glycol
6.1.2.11 Acrylic Polymers
6.1.3 Alcohols
6.1.3.1 Glycerin
6.1.3.2 Propylene Glycol
6.1.3.3 Sorbitol
6.1.3.4 Mannitol
6.1.3.5 Others
6.1.4 Sugars
6.1.4.1 Lactose
6.1.4.2 Sucrose
6.1.4.3 Others
6.1.5 Minerals
6.1.5.1 Calcium Phosphate
6.1.5.2 Calcium Carbonate
6.1.5.3 Calcium Sulfate
6.1.5.4 Clay
6.1.5.5 Silicon Dioxide
6.1.5.6 Titanium Dioxide
6.1.5.7 Others
6.1.6 Gelatins
6.1.7 Others
6.2 Global Pharmaceutical Excipients Market by Functionality
6.2.1 Market Overview
6.2.2 Binders and Adhesives
6.2.2.1 Organic
6.2.2.2 Inorganic
6.2.3 Disintegrants
6.2.3.1 Organic
6.2.3.2 Inorganic
6.2.4 Coating Material
6.2.4.1 Organic
6.2.4.2 Inorganic
6.2.5 Coloring Agents
6.2.5.1 Organic
6.2.5.2 Inorganic
6.2.6 Solubilizers
6.2.6.1 Organic
6.2.6.2 Inorganic
6.2.7 Flavors
6.2.7.1 Organic
6.2.7.2 Inorganic
6.2.8 Sweetening Agents
6.2.8.1 Organic
6.2.8.2 Inorganic
6.2.9 Diluents
6.2.9.1 Organic
6.2.9.2 Inorganic
6.2.10 Lubricants
6.2.10.1 Organic
6.2.10.2 Inorganic
6.2.11 Buffers
6.2.11.1 Organic
6.2.11.2 Inorganic
6.2.12 Emulsifying Agents
6.2.12.1 Organic
6.2.12.2 Inorganic
6.2.13 Preservatives
6.2.13.1 Organic
6.2.13.2 Inorganic
6.2.14 Antioxidants
6.2.14.1 Organic
6.2.14.2 Inorganic
6.2.15 Sorbents
6.2.15.1 Organic
6.2.15.2 Inorganic
6.2.16 Solvents
6.2.16.1 Organic
6.2.16.2 Inorganic
6.2.17 Emollients
6.2.17.1 Organic
6.2.17.2 Inorganic
6.2.18 Glidants
6.2.18.1 Organic
6.2.18.2 Inorganic
6.2.19 Chelating Agents
6.2.19.1 Organic
6.2.19.2 Inorganic
6.2.20 Antifoaming Agents
6.2.20.1 Organic
6.2.20.2 Inorganic
6.2.21 Others
6.3 Global Pharmaceutical Excipients Market by End User
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biopharmaceutical Companies
6.3.3 Contract Formulators
6.3.4 Research Organization and Academics
6.3.5 Others
6.4 Global Pharmaceutical Excipients Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Direct Tender
6.4.3 Retail Sales
6.4.4 E-Commerce
6.4.5 Others
6.5 Global Pharmaceutical Excipients Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Pharmaceutical Excipients Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pharmaceutical Excipients Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pharmaceutical Excipients Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pharmaceutical Excipients Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pharmaceutical Excipients Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Kerry Group plc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 DFE Pharma
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Cargill
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Incorporated
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Pfanstiehl
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Colorcon
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 MEGGLE GmbH & Co. KG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Roquette Frères
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 The Lubrizol Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BASF SE
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Avantor Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BENEO
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Chemie Trade
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Pharmaceutical Excipients Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2022, the global pharmaceutical excipients market attained a value of nearly USD 8.3 billion.
The market is projected to grow at a CAGR of 4.1% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 10.6 billion by 2028.
The major drivers expected to aid the market growth are the growth of the pharmaceutical sector, rising demand for OTC drugs, advancements in biotechnology, and the development of the multifunctional excipients.
The key market trends guiding the growth of the pharmaceutical excipients market include growing technological advancements, and the launch of new products owing to increased research and development activities.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Organic chemicals and inorganic chemicals, among others, are the leading pharmaceutical excipients products in the market.
Oral formulations, topical formulations, and parenteral formulations, among others, are the major formulations of the product in the market.
The significant functionalities of the product in the market include fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others.
The major players in the global pharmaceutical excipients market are DuPont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., and WACKER Chemie AG, among others.
The global pharmaceutical excipients market attained a value of USD 8.3 billion in 2022, driven by the thriving pharmaceuticals sector and the growing demand for multifunctional excipients. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4.1%. The pharmaceutical excipients market is projected to reach USD 10.6 billion by 2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the pharmaceutical excipients industry can be bifurcated into organic chemicals and inorganic chemicals, among others. On the basis of formulation, the industry can be categorised into oral formulations, topical formulations, and parenteral formulations, among others. By functionality, the market is segregated into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others. The major regional markets for pharmaceutical excipients are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Dupont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., WACKER Chemie AG, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.